Banys-Paluchowski, M., Loibl, S., Witzel, I., Mundhenke, C., Lederer, B., Solbach, C., . . . Müller, V. (2019). Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial. MDPI AG.
Trích dẫn kiểu ChicagoBanys-Paluchowski, Malgorzata, et al. Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated With Neoadjuvant Therapy in the GeparQuinto Trial. MDPI AG, 2019.
Trích dẫn MLABanys-Paluchowski, Malgorzata, et al. Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated With Neoadjuvant Therapy in the GeparQuinto Trial. MDPI AG, 2019.